Copd: Difference between revisions

Line 119:

*"visual assessment of lung HRCT scans showed no pathological findings in people vaping daily for more than 3.5 years. In particular, no CT features compatible with early signs of COPD (i.e. parenchymal micronodules, ground-glass opacity, or macroscopic emphysema) or lipoid pneumonia or popcorn lung disease were present." (Polosa)

*Referring to: Eissenberg T, Maziak W. Are Electronic Cigarette Users at Risk for Lipid-mediated Lung Injury? Am J Respir Crit Care Med. 2020 Apr 15;201(8):1012-1013. [https://pubmed.ncbi.nlm.nih.gov/31917600/ doi: 10.1164/rccm.201910-2082LE]. PMID: 31917600; PMCID: PMC7159422.

===2020: [https://www.sciencemediacentre.org/expert-reaction-to-review-of-the-effects-of-tobacco-cigarettes-e-cigarettes-and-waterpipe-use-on-the-body-and-clinical-outcomes/ expert reaction to review of the effects of tobacco cigarettes, e-cigarettes and waterpipe use on the body and clinical outcomes]===

*Prof John Britton, Director of the UK Centre for Tobacco & Alcohol Studies and Consultant in Respiratory Medicine, University of Nottingham, said:

**“This paper provides an unsystematic overview on evidence relating to the likely relative risks of nicotine use, and of questionable reliability: for example, that e-cigarette use increases the risk of chronic obstructive pulmonary disease by 194% but COPD is a disease with a lead time of decades, so to attribute a risk directly to e-cigarettes – which have been widely used for less than a decade and are almost exclusively used by former smokers – is inappropriate.”

===2019-2020: Comments RE: [https://pubpeer.com/publications/7571819CEB7A2BC425BE3D7061410D Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis]===

@@ Line 119: / Line 119: @@
 *"visual assessment of lung HRCT scans showed no pathological findings in people vaping daily for more than 3.5 years. In particular, no CT features compatible with early signs of COPD (i.e. parenchymal micronodules, ground-glass opacity, or macroscopic emphysema) or lipoid pneumonia or popcorn lung disease were present." (Polosa)
 *Referring to: Eissenberg T, Maziak W. Are Electronic Cigarette Users at Risk for Lipid-mediated Lung Injury? Am J Respir Crit Care Med. 2020 Apr 15;201(8):1012-1013. [https://pubmed.ncbi.nlm.nih.gov/31917600/ doi: 10.1164/rccm.201910-2082LE]. PMID: 31917600; PMCID: PMC7159422.
+===2020: [https://www.sciencemediacentre.org/expert-reaction-to-review-of-the-effects-of-tobacco-cigarettes-e-cigarettes-and-waterpipe-use-on-the-body-and-clinical-outcomes/ expert reaction to review of the effects of tobacco cigarettes, e-cigarettes and waterpipe use on the body and clinical outcomes]===
+*Prof John Britton, Director of the UK Centre for Tobacco & Alcohol Studies and Consultant in Respiratory Medicine, University of Nottingham, said:
+**“This paper provides an unsystematic overview on evidence relating to the likely relative risks of nicotine use, and of questionable reliability: for example, that e-cigarette use increases the risk of chronic obstructive pulmonary disease by 194% but COPD is a disease with a lead time of decades, so to attribute a risk directly to e-cigarettes – which have been widely used for less than a decade and are almost exclusively used by former smokers – is inappropriate.”
 ===2019-2020: Comments RE: [https://pubpeer.com/publications/7571819CEB7A2BC425BE3D7061410D Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis]===